ANTI — Antigenics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Antigenics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	1996 December 31st	1997 December 31st	1998 December 31st	1999 December 31st	2000 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K405	10-K405	10-K405	10-K
Standards:	—	—	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	34.6	19.8	19.1	19.3	8.25
Net Total Accounts Receivable
Net Total Receivables	0.078	0.1	0.132	0	—
Prepaid Expenses
Total Current Assets	35.3	20.4	19.5	19.8	8.37
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.15	1.11	2.26	2.03	1.85
Long Term Investments
Other Long Term Assets
Total Assets	44.3	32.1	23	22.7	11
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.66	4.74	8.42	4.49	4.76
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.8	4.75	9.44	8	8.38
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	40.5	27.4	13.6	14.7	2.67
Total Liabilities & Shareholders' Equity	44.3	32.1	23	22.7	11
Total Common Shares Outstanding